Breast-conservation treatment for bilateral breast cancer in five Japanese women

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 469-474

  Hamada, Norihiko ^a,b   Ogawa, Yasuhiro ^b   Nishioka, Akihito ^b   Kariya, Shinji ^b   Terashima, Masako ^b   Yoshida, Shoji ^b   Tochika, Naoshige ^b   Tanaka, Yohsuke ^b   Kumon, Masamitsu ^c   Inomata, Taisuke ^d  

^a Hosogi Hospital   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c Noichi Central Hospital   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Bilateral breast cancer; Breast conservation treatment

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG DERIVATIVE; FLUOROURACIL; PIRARUBICIN; TAMOXIFEN; TOREMIFENE;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; JAPAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; RECURRENT DISEASE; SEGMENTAL MASTECTOMY; TIME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; JAPAN; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RECURRENCE; TAMOXIFEN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TOREMIFENE;

EID: 0036583339     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.469     Document Type: Article

References (32)

1. Kato I, Miura S, Yoshida M and Tominaga S: Risk factors of multiple primary cancers in breast cancer patients. Jpn J Cancer Res 77: 296-304, 1986. (Pubitemid 16101933)
2. Iino Y, Ishikita T, Takeo T, Yokoe T, Sugamata N, Takai Y, Aoyagi H, Maemura M, Horiguchi J and Takei H: Subcutaneous mastectomy with axillary dissection for early breast cancer. Anticancer Res 13: 1183-1186, 1993. (Pubitemid 23247486)
3. Hatada T, Aoki I, Ikeda H, Tamura T, Okada K, Nakai T and Utsunomiya J: Dermatomyositis and malignancy: case report and review of the Japanese literature. Tumori 82: 273-275, 1996. (Pubitemid 26253726)
4. Ito K, Kurai M, Fujimori M, Hama Y, Shingu K, Kobayashi S, Yamagami O, Matsuyama I, Tsuchiya S and Amano J: Bilateral synchronous spindle cell, apocrine and scirrhous carcinoma breast cancer in a case of malignant lymphoma. Breast Cancer Res Treat 25: 411-416, 1998.
5. Nakayama H, Masuda H, Ugajin W, Nakamura Y, Akiyama K, Suzuki K and Amano S: Quadruple cancer including bilateral breasts, Vater's papilla, and urinary bladder: report of a case. Surg Today 29: 276-279, 1999. (Pubitemid 29119849)
6. Tsuboi N, Ogawa Y, Inomata T, Yoshida D, Yoshida S, Moriki T and Kumon M: Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6: 727-732, 1999.
7. Hata Y, Ogawa Y, Nishioka A, Inomata T and Yoshida S: Thin section computed tomography in the prone position for detection of axillary lymph node metastases in breast cancer. Oncol Rep 5: 1403-1406, 1998. (Pubitemid 28474084)
8. Fisher ER, Fisher B, Sass R, Wickerham L and collaborating NSABP investigators: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) XI. Bilateral breast cancer. Cancer 54: 3002-3011, 1984. (Pubitemid 15184085)
9. Fung MC, Schultz DJ and Solin LJ: Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the university of Pennsylvania experience. Int J Radiat Oncol Biol Phys 38: 959-967, 1997. (Pubitemid 27353674)
10. Gollamudi SV, Gelman RS, Peiro G, Schneider LJ, Schnitt SJ, Recht A, Silver BJ, Harris JR and Connolly JL: Breast-conserving therapy for stage I-II synchronous bilateral breast carcinoma. Cancer 79: 1362-1369, 1997. (Pubitemid 27143244)
11. De la Rochefordiere A, Asselain B, Scholl S, Campana F, Ucla L, Vilcoq JR, Durand JC, Pouillart P and Fourquet A: Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 30: 35-41, 1994. (Pubitemid 24291111)
12. Mose S, Adamietz IA, Thilmann C, Saran F, Bernhard M, Pahnke R and Bottcher HD: Bilateral breast carcinoma versus unilateral disease. Review of 498 patients. Am J Clin Oncol 20: 541-545, 1997. (Pubitemid 27509874)
13. Kollias J, Ellis IO, Elston CW and Blamey RW: Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 25: 1117-1124, 2001. (Pubitemid 32845821)
14. Gustafsson Å, Tartter PI, Brower ST and Lesnick G: Prognosis of patients with bilateral carcinoma of the breast. J Am Coll Surg 178: 111-116, 1994. (Pubitemid 24073486)
15. Solin LJ, Fowble BL, Schultz DJ and Goodman RL: Bilateral breast carcinoma treated with definitive irradiation. Int J Radiat Oncol Biol Phys 17: 263-271, 1989. (Pubitemid 19203071)
16. Lee MM, Heimann R, Powers C, Weichselbaum RR and Chen LM: Efficacy of breast conservation therapy in early stage bilateral breast cancer. Breast J 5: 36-41, 1999. (Pubitemid 29108807)
17. Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, McNeese MD and Hunt KK: Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol 6: 102-108, 1999. (Pubitemid 29077495)
18. Chevallier B, Mignot L, Delozier T, Morvan F, Ferme C and Herait P: Phase II study of tetrahydropyranyl adriamycin (pirarubicin) in elderly patients with advanced breast cancer. Am J Clin Oncol 15: 395-398, 1992.
19. Herait P, Poutignat N, Marty M and Bugat R: Early assessment of a new anticancer drug analogue - are the historical comparisons obsolete? the French experience with pirarubicin. Eur J Cancer 28A: 1670-1676, 1992.
20. Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A and Hortobagyi GN: Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Clin Cancer Res 1: 691-697, 1995.
21. Ogawa Y, Nishioka A, Inomata T, Ohnishi T, Kariya S, Terashima M, Yoshida S, Tohchika N, Tanaka Y and Kumon M: Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer. Oncol Rep 7: 479-484, 2000.
22. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 333: 1444-1455, 1995.
23. Ogawa Y, Nishioka A, Inomata T, Yokota N, Sasaki T, Terashima M, Yoshida S, Tanaka Y and Tohchika N: Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes. Oncol Rep 6: 801-805, 1999.
24. Pinto HC, Baptista A, Camilo ME, De Costa EB, Valente A and De Moura MC: Tamoxifen-associated steatohepatitis, report of three cases. J Hepatol 23: 95-97, 1995.
25. Pratt DS, Knox TA and Erban J: Tamoxifen-induced steatohepatitis. Ann Intern Med 123: 236, 1995.
26. Van Hoof M, Rahier J and Horsmans Y: Tamoxifen-induced steatohepatitis. Ann Intern Med 124: 855-856, 1996.
27. Oien KA, Moffat D, Curry GW, Dickson J, Habeshaw T, Mills PR and MacSween RNM: Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 353: 36-37, 1999. (Pubitemid 29037704)
28. Ogawa Y, Murata Y, Nishioka A, Inomata T and Yoshida S: Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 351: 725, 1998. (Pubitemid 28105346)
29. Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Ohnishi S and Yoshida S: Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol Rep 7: 1299-1304, 2000.
30. Hamada N, Ogawa Y, Saibara T, Murata Y, Kariya S, Nishioka A, Terashima M, Inomata T and Yoshida S: Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment. Int J Oncol 17: 1119-1123, 2000.
31. Fracchia AA, Robinson D, Legaspi A, Greenall MJ, Kinne DW and Groshen S: Survival in bilateral breast cancer. Cancer 55: 1414-1421, 1985. (Pubitemid 15143424)
32. Engin K: Prognostic factors in bilateral breast cancer. Neoplasma 41: 353-357,1994.